Benefits Canada report on the Face to Face Drug Plan Management Forum held on December 9, 2020.
Who we are
Biosimilars Canada is a national association representing the biosimilar medicines industry in Canada. We provide leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines, and advocate for policies that support their timely approval, reimbursement, market acceptance and expanded use.
Learn more about biosimilars and their benefits for patients and healthcare systems.
This Benefits Canada article highlights the importance of maximizing the use of biosimilar and generic medicines to ensure plan sustainability.
Biosimilars Canada is participating in this globally aligned educational initiative to raise awareness of biosimilar medicines from November 16 to 20.